Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DBVT | AZN | AMGN | GILD | BMY |
| Company | Dbv Technologies ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 20.27 | 181.48 | 321.91 | 132.84 | 57.00 |
| High | 20.65 | 181.98 | 329.66 | 133.98 | 57.48 |
| Low | 19.22 | 180.00 | 320.52 | 131.89 | 56.73 |
| Latest | 19.49 | 181.24 | 329.59 | 133.48 | 56.95 |
| Change | +0.02 | -2.22 | +5.74 | +0.79 | -0.43 |
| % Change | +0.10% | -1.21% | +1.77% | +0.60% | -0.75% |
| Volume | 249,100 | 2,459,900 | 3,321,400 | 6,152,400 | 11,316,601 |
| 20-Day Average Volume | 217,420 | 2,018,395 | 2,631,795 | 5,477,055 | 10,039,115 |
| Previous Close | 19.47 | 183.46 | 323.85 | 132.69 | 57.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 20.58 | 194.80 | 344.58 | 134.93 | 58.61 |
| 20-Day Raw Stochastic | 13.84% | 4.54% | 23.30% | 38.10% | 5.39% |
| 20-Day Relative Strength | 45.64 | 36.62 | 39.78 | 44.79 | 44.75 |
| Weighted Alpha | +38.95 | +25.87 | +17.75 | +30.17 | +22.69 |
| Today's Opinion | 8% Buy | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 24% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 40% Buy | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.30% since 04/28/26 | -2.91% since 04/28/26 | -2.94% since 04/28/26 | +3.26% since 04/28/26 | -2.25% since 04/28/26 |
| Low | 18.92 on 05/04/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 56.73 on 05/05/26 |
| High | 21.38 on 04/30/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 133.98 on 05/05/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -7.45% since 04/02/26 | -10.93% since 04/02/26 | -5.27% since 04/02/26 | -4.46% since 04/02/26 | -4.45% since 04/02/26 |
| Low | 18.92 on 05/04/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.73 on 05/05/26 |
| High | 23.04 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -9.18% since 02/05/26 | -3.16% since 02/05/26 | -10.39% since 02/05/26 | -10.64% since 02/05/26 | -4.32% since 02/05/26 |
| Low | 18.61 on 03/11/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 24.65 on 02/10/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +38.23% since 11/05/25 | +11.67% since 11/05/25 | +3.04% since 11/05/25 | +8.89% since 11/05/25 | +22.55% since 11/05/25 |
| Low | 12.56 on 11/13/25 | 166.74 on 11/06/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 26.18 on 12/17/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,083,895 | 284,529,568 | 174,776,976 | 164,697,760 | 117,154,760 |
| Shares Outstanding, K | 55,670 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 5,640,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -146,950,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 900,000 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -47,600,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | -0.96 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.15 on 03/26/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/04/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.95 | 14.92 | 16.15 | 9.82 |